Table 2.
The biological subtypes of breast cancer.
| Subtypes | Estrogen receptor (ER) |
Human epidermal growth factor receptor-2 (HER2) | Ki-67 protein |
Progesterone receptor (PR) |
Comment |
|---|---|---|---|---|---|
| Luminal A Luminal B |
Positive Positive |
Negative Positive or Negative |
Low High |
Positive or Negative Positive or Negative |
In comparing luminal A and B, luminal A is reported to be growing slower than luminal B, which means best prognosis in luminal A cancer; Ki-67 helps in monitoring how fast tumours grow. |
|
| |||||
| Triple-negative (basal-like) | Negative | Negative | - | Negative | It is defined as basal-like breast cancer and is more common among young women especially with BRCA1 gene mutations. |
|
| |||||
| HER2-enriched | Negative | Positive | - | Negative | This cancer is growing faster than luminal cancers but with worse prognosis. |
|
| |||||
| Normal-like | Positive | Negative | Low | Positive or Negative | Although ‘normal-like' is similar to luminal A, its prognosis is worse than luminal A. |